中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
15期
24-27
,共4页
肿瘤型假体%恶性骨肿瘤%重建
腫瘤型假體%噁性骨腫瘤%重建
종류형가체%악성골종류%중건
The tumor type prosthetic%Malignant bone tumors%Reconstruction
目的:对应用定制肿瘤型人工假体置换治疗恶性骨肿瘤的临床疗效进行分析。方法回顾性分析我科2009年5月~2013年2月收治的恶性骨肿瘤患者29例,男18例,女11例;年龄17~65岁,平均38.5岁,股骨上端5例,股骨远端14例,胫骨上端7例,股骨下端3例。所有患者均接受对肿瘤进行广泛切除或根治性切除,包括综合性治疗及定制型人工假体置换治疗,术后对患者进行定期随访,对治疗效果进行评价。结果置换后1年采用MSTS保肢评分系统对随访患者进行功能评价,显示股骨远端患者(15.5~28.0)分,平均23.5分;股骨上端0.5~29.0分,平均23.5分;胫骨近端10.5~29.0分,平均22.4分。其中优9例,良15例,中4例,差1例,优良率为82.7%。术后并发症发生率为10.0%。1例患者于术后7个月死亡,1例患者于术后18个月后肺转移死亡,1例在术后13个月时出现局部复发现象而截肢,1例在术后8个月时出现局部复发单纯行瘤体切除。在随访时,所有患者均未出现人工假体断裂、松动现象。结论在骨肿瘤患者采用人工假体置换术前、术后给予综合性治疗,在对肢体功能加以保留,与其他重建方法相比,具有肢体早期负重、功能恢复快、使用期长的优点,患者生活质量大幅提高,是骨肿瘤保肢治疗的较理想选择,值得在临床中推广。
目的:對應用定製腫瘤型人工假體置換治療噁性骨腫瘤的臨床療效進行分析。方法迴顧性分析我科2009年5月~2013年2月收治的噁性骨腫瘤患者29例,男18例,女11例;年齡17~65歲,平均38.5歲,股骨上耑5例,股骨遠耑14例,脛骨上耑7例,股骨下耑3例。所有患者均接受對腫瘤進行廣汎切除或根治性切除,包括綜閤性治療及定製型人工假體置換治療,術後對患者進行定期隨訪,對治療效果進行評價。結果置換後1年採用MSTS保肢評分繫統對隨訪患者進行功能評價,顯示股骨遠耑患者(15.5~28.0)分,平均23.5分;股骨上耑0.5~29.0分,平均23.5分;脛骨近耑10.5~29.0分,平均22.4分。其中優9例,良15例,中4例,差1例,優良率為82.7%。術後併髮癥髮生率為10.0%。1例患者于術後7箇月死亡,1例患者于術後18箇月後肺轉移死亡,1例在術後13箇月時齣現跼部複髮現象而截肢,1例在術後8箇月時齣現跼部複髮單純行瘤體切除。在隨訪時,所有患者均未齣現人工假體斷裂、鬆動現象。結論在骨腫瘤患者採用人工假體置換術前、術後給予綜閤性治療,在對肢體功能加以保留,與其他重建方法相比,具有肢體早期負重、功能恢複快、使用期長的優點,患者生活質量大幅提高,是骨腫瘤保肢治療的較理想選擇,值得在臨床中推廣。
목적:대응용정제종류형인공가체치환치료악성골종류적림상료효진행분석。방법회고성분석아과2009년5월~2013년2월수치적악성골종류환자29례,남18례,녀11례;년령17~65세,평균38.5세,고골상단5례,고골원단14례,경골상단7례,고골하단3례。소유환자균접수대종류진행엄범절제혹근치성절제,포괄종합성치료급정제형인공가체치환치료,술후대환자진행정기수방,대치료효과진행평개。결과치환후1년채용MSTS보지평분계통대수방환자진행공능평개,현시고골원단환자(15.5~28.0)분,평균23.5분;고골상단0.5~29.0분,평균23.5분;경골근단10.5~29.0분,평균22.4분。기중우9례,량15례,중4례,차1례,우량솔위82.7%。술후병발증발생솔위10.0%。1례환자우술후7개월사망,1례환자우술후18개월후폐전이사망,1례재술후13개월시출현국부복발현상이절지,1례재술후8개월시출현국부복발단순행류체절제。재수방시,소유환자균미출현인공가체단렬、송동현상。결론재골종류환자채용인공가체치환술전、술후급여종합성치료,재대지체공능가이보류,여기타중건방법상비,구유지체조기부중、공능회복쾌、사용기장적우점,환자생활질량대폭제고,시골종류보지치료적교이상선택,치득재림상중추엄。
Objective To analyze the clinical efficacy of the treatment of malignant bone tumors with the replacement of Customized tumor type prosthetic. Methods From May 2009 to February 2013, we did a retrospective analysis about 29 cases suffered malignant bone tumors, there were 18 males and 11 females, with average age of 38.5 years (ranged from 17 to 65).5 cases on the proximal femur, 14 cases on the distal femur,7 cases on the proximal tibia, 3 cases on the distal tibia, which all treated by extensive excision or radical excision of the tumor including comprehensive treatment and the replacement of Customized tumor type prosthetic. Then analyzed the results of the treatment by following up. Results All patients were followed up with one year after surgery, to evaluate the function with MSTS limb salvage score system. The MSTS score was average 23.5 scores(ranged from 15.5 to 28.0) of the distal femur, and averaged 23.5 scores (ranged from 0.5 to 29.0) of the proximal femur, and averaged 22.4 scores (ranged from 10.5 to 29.0) of the proximal tibia. excellent 9 cases, good 15 cases, fair 4 cases and poor 1 cases. Excellent and good rate was 82.7%.The rate of Postoperative complication was 10.0%.One patient died after 7 months of surgery. One patient died of lung metastasis after 18 months of surgery. One patient amputated for local recurrence after 13 months of surgery. One patient suffered tumor resection for local recurrence after 8 months of surgery. There was no case what occurred the complications of prosthesis fracture and loosening. Conclusion The patients who were suffered malignant bone tumors, treated by the replacement of Customized tumor type prosthetic, and comprehensive treated before and after the surgery, then retain the function of the limb. There were advantages of early weight bearing, rapid recovery and using a long period compared with other reconstruction, significantly improve the quality of life of patients. It is an ideal treatment of the bone tumor and worth promoting in clinical.